Placental volume and other first-trimester outcomes: are there differences between fresh embryo transfer, frozen-thawed embryo transfer and natural conception?


Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 22 06 2018
revised: 20 09 2018
accepted: 10 12 2018
pubmed: 10 3 2019
medline: 9 6 2020
entrez: 10 3 2019
Statut: ppublish

Résumé

Does mode of conception influence placental volume and other first-trimester outcomes? This retrospective single-centre case-control study led in Dijon University Hospital included 252 singleton pregnancies (84 IVF with either fresh embryo transfer or frozen-thawed embryo transfer [FET] and 168 natural conceptions). First-trimester placental volume, uterine artery pulsatility index and maternal serum PAPP-A and beta-HCG were measured. Statistical analyses were adjusted for gestational age, the newborn's gender, maternal age, parity, body mass index and smoking status. Placental volume was significantly greater in the FET group than in the control group (P = 0.043) and fresh embryo transfer (P = 0.023) groups. At birth, fresh embryo transfer newborns were significantly smaller than controls (P = 0.01) and FET newborns (P = 0.008). Postpartum haemorrhage was far more frequent in FET than in controls and fresh embryo transfer group (38.1%, 2.6% and 1.9%, respectively; P < 0.0001). Placental volume positively correlated with PAPP-A, beta-HCG and the newborn's birth weight, and negatively correlated with uterine artery pulsatility index. Placental volume and other first-trimester parameters are modified by IVF with fresh embryo transfer and FET compared with natural conception, but with opposite trends. Given the different protocols used for these techniques, hormonal treatment per se may have a major effect on pregnancy outcomes through the modification of placental invasiveness.

Identifiants

pubmed: 30850320
pii: S1472-6483(18)30652-7
doi: 10.1016/j.rbmo.2018.12.023
pii:
doi:

Substances chimiques

Chorionic Gonadotropin, beta Subunit, Human 0
Peptide Fragments 0
urinary gonadotropin fragment 0
Pregnancy-Associated Plasma Protein-A EC 3.4.24.-
PAPPA protein, human EC 3.4.24.79

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

538-548

Informations de copyright

Copyright © 2019 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Auteurs

Cécile Choux (C)

Dijon University Hospital, Fetal Health and Infertility Department, Dijon F-21000, France. Electronic address: cecile.choux@chu-dijon.fr.

Perrine Ginod (P)

Dijon University Hospital, Fetal Health and Infertility Department, Dijon F-21000, France.

Julie Barberet (J)

Dijon University Hospital, Reproductive Biology Department, Dijon F-21000, France.

Thierry Rousseau (T)

Dijon University Hospital, Fetal Health and Infertility Department, Dijon F-21000, France.

Céline Bruno (C)

Dijon University Hospital, Reproductive Biology Department, Dijon F-21000, France.

Paul Sagot (P)

Dijon University Hospital, Fetal Health and Infertility Department, Dijon F-21000, France.

Karine Astruc (K)

Dijon University Hospital, Epidemiology Unit, Dijon F-21000, France.

Patricia Fauque (P)

Dijon University Hospital, Reproductive Biology Department, Dijon F-21000, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH